<abstract xmlns="http://www.w3.org/1999/xhtml"><sec id="j_raon-2016-0038_s_333_w2aab3b8c92b1b7b1aab1c16b1Aa"><h3>Background</h3><p>The aim of the study was to establish whether there are different clinical entities of primary pulmonary choriocarcinoma (PPC) that deserve different diagnostic approach and the most optimal treatment.</p></sec><sec id="j_raon-2016-0038_s_334_w2aab3b8c92b1b7b1aab1c16b2Aa"><h3>Patients and methods</h3><p>A systematic review with PubMed search was conducted to identify studies that reported cases of PPC. The eligibility criteria were histological diagnosis of pulmonary choriocarcinoma and thorough examination of the reproductive organs to exclude potential primary choriocarcinoma in the gonads. Furthermore, to illustrate the review we additionally present a patient referred at our institution.</p></sec><sec id="j_raon-2016-0038_s_335_w2aab3b8c92b1b7b1aab1c16b3Aa"><h3>Results</h3><p>55 cases (17 men) were included in the review with a median age of 34 years. Women with the history of gestational event showed better survival outcome than women without the history of gestational event. Patients treated with combined modality treatment (surgery and chemotherapy) survived longer than the patients without combined modality treatment. Furthermore, multivariate analysis of prognostic factors showed that the combined modality treatment had independent prognostic significance. Size of the tumour showed significant prognostic influence in univariate and multivariate analysis.</p></sec><sec id="j_raon-2016-0038_s_336_w2aab3b8c92b1b7b1aab1c16b4Aa"><h3>Conclusions</h3><p>PPC is an extreme rarity with variable clinical characteristics and outcome. It is important to capture and treat patients in the early stages of the disease. Women with the history of gestational event may show better survival, therefore genetic examination could help us to predict patient’s prognosis. Surgery followed by adjuvant chemotherapy appears to represent the best treatment for PPC.</p></sec></abstract>

BackgroundThe aim of the study was to establish whether there are different clinical entities of primary pulmonary choriocarcinoma (PPC) that deserve different diagnostic approach and the most optimal treatment.Patients and methodsA systematic review with PubMed search was conducted to identify studies that reported cases of PPC. The eligibility criteria were histological diagnosis of pulmonary choriocarcinoma and thorough examination of the reproductive organs to exclude potential primary choriocarcinoma in the gonads. Furthermore, to illustrate the review we additionally present a patient referred at our institution.Results55 cases (17 men) were included in the review with a median age of 34 years. Women with the history of gestational event showed better survival outcome than women without the history of gestational event. Patients treated with combined modality treatment (surgery and chemotherapy) survived longer than the patients without combined modality treatment. Furthermore, multivariate analysis of prognostic factors showed that the combined modality treatment had independent prognostic significance. Size of the tumour showed significant prognostic influence in univariate and multivariate analysis.ConclusionsPPC is an extreme rarity with variable clinical characteristics and outcome. It is important to capture and treat patients in the early stages of the disease. Women with the history of gestational event may show better survival, therefore genetic examination could help us to predict patient’s prognosis. Surgery followed by adjuvant chemotherapy appears to represent the best treatment for PPC.

Primary pulmonary choriocarcinoma

Radiology and Oncology

This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

{"article-title":"Primary pulmonary choriocarcinoma"}

BackgroundThe aim of the study was to establish whether there are different clinical entities of primary pulmonary choriocarcinoma (PPC) that deserve different...

Primary pulmonary choriocarcinoma

Article Category: Research Article

Publié en ligne: 24 juin 2016

Pages: 1 - 7

Reçu: 18 mars 2015

Accepté: 20 mai 2016

DOI: https://doi.org/10.1515/raon-2016-0038

© 2017 Ziga Snoj, Igor Kocijancic, Erik Skof

This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.